Prehabilitation for adults diagnosed with cancer: A systematic review of long-term physical function, nutrition and patient-reported outcomes.


Journal

European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 21 11 2017
revised: 21 09 2018
accepted: 17 01 2019
pubmed: 13 3 2019
medline: 25 1 2020
entrez: 13 3 2019
Statut: ppublish

Résumé

Prehabilitation is increasingly being used to mitigate treatment-related complications and enhance recovery. An individual's state of health at diagnosis, including obesity, physical fitness and comorbidities, are influencing factors for the occurrence of adverse effects. This review explores whether prehabilitation works in improving health outcomes at or beyond the initial 30 days post-treatment and considers the utility of prehabilitation before cancer treatment. A database search was conducted for articles published with prehabilitation as a pre-cancer treatment intervention between 2009 and 2017. Studies with no 30 days post-treatment data were excluded. Outcomes post-prehabilitation were extracted for physical function, nutrition and patient-reported outcomes. Sixteen randomised controlled trials with a combined 2017 participants and six observational studies with 289 participants were included. Prehabilitation interventions provided multi-modality components including exercise, nutrition and psychoeducational aspects. Prehabilitation improved gait, cardiopulmonary function, urinary continence, lung function and mood 30 days post-treatment but was not consistent across studies. When combined with rehabilitation, greater benefits were seen in 30-day gait and physical functioning compared to prehabilitation alone. Large-scale randomised studies are required to translate what is already known from feasibility studies to improve overall health and increase long-term cancer patient outcomes.

Identifiants

pubmed: 30859650
doi: 10.1111/ecc.13023
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Pagination

e13023

Informations de copyright

© 2019 Crown copyright. European Journal of Cancer Care © 2019 John Wiley & Sons Ltd.

Auteurs

Sara Faithfull (S)

School of Health Sciences, Faculty of Health & Medical Sciences, University of Surrey, Guildford, UK.

Lauren Turner (L)

Frimley Health NHS Foundation Trust, Frimley, Surrey, UK.

Karen Poole (K)

School of Health Sciences, Faculty of Health & Medical Sciences, University of Surrey, Guildford, UK.

Mark Joy (M)

School of Health Sciences, Faculty of Health & Medical Sciences, University of Surrey, Guildford, UK.

Ralph Manders (R)

Exercise Physiology and Sports Science, University Surrey, Guildford, UK.

Jennifer Weprin (J)

School of Nursing, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.

Kerri Winters-Stone (K)

School of Nursing, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.

John Saxton (J)

Department of Sport Exercise and Rehabilitation, Northumbria University, Newcastle Upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH